Cargando…

Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults

BACKGROUND: Little is known about factors associated with maintenance of hemagglutinin inhibition (HAI) antibodies after influenza vaccination in older adults. METHODS: Adults ≥50 years of age were vaccinated prior to the 2009–10 influenza season. Serum was drawn pre-vaccination (S1), 21–28 days pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Talbot, H Keipp, Coleman, Laura A, Zhu, Yuwei, Spencer, Sarah, Thompson, Mark, Cheng, Po-Yung, Sundaram, Maria E, Belongia, Edward A, Griffin, Marie R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415221/
https://www.ncbi.nlm.nih.gov/pubmed/25903659
http://dx.doi.org/10.1186/s12879-015-0926-8
_version_ 1782369035844845568
author Talbot, H Keipp
Coleman, Laura A
Zhu, Yuwei
Spencer, Sarah
Thompson, Mark
Cheng, Po-Yung
Sundaram, Maria E
Belongia, Edward A
Griffin, Marie R
author_facet Talbot, H Keipp
Coleman, Laura A
Zhu, Yuwei
Spencer, Sarah
Thompson, Mark
Cheng, Po-Yung
Sundaram, Maria E
Belongia, Edward A
Griffin, Marie R
author_sort Talbot, H Keipp
collection PubMed
description BACKGROUND: Little is known about factors associated with maintenance of hemagglutinin inhibition (HAI) antibodies after influenza vaccination in older adults. METHODS: Adults ≥50 years of age were vaccinated prior to the 2009–10 influenza season. Serum was drawn pre-vaccination (S1), 21–28 days post-vaccination (S2), and after the influenza season (S3) for HAI assays. Seroconversion was defined as ≥ 4-fold increase S1 to S2 (or if S1 < 10, by an S2 ≥ 40) and seroprotection was defined as S2 ≥ 40. Maintenance of antibody response was measured in participants with an S2 ≥ 40, and defined as an S3 ≥ 40. RESULTS: We enrolled 510 participants during Fall 2009 at Vanderbilt University Medical Center and Marshfield Clinic Research Foundation. Participants’ mean age was 64 years with 62% female and 96% white. Seroconversion and seroprotection rates were lowest for influenza A H1N1 (12% and 26%, respectively), highest for influenza A H3N2 (45% and 82%), and intermediate for influenza B (28% and 72%). Of the participants with an S2 ≥ 40, 36% (46/126), 71% (289/407), and 74% (263/354) maintained an S3 ≥ 40 for H1N1, H3N2, and B influenza vaccine strains, respectively. S1 HAI titer was strongly associated with both post-vaccination seroprotection and maintaining seroprotection at S3 for all three influenza antigens. Age, sex, body mass index, self-reported stress, and vaccination site were not consistently associated with vaccine response or maintenance of response. CONCLUSIONS: Pre-vaccination antibody titer was the only study variable consistently and positively associated with both serologic response to vaccination and maintenance of response. Antibody responses were lowest for the H1N1 vaccine strain. CLINICALTRIALS: gov Identifier: NCT02401893 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-015-0926-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4415221
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44152212015-05-01 Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults Talbot, H Keipp Coleman, Laura A Zhu, Yuwei Spencer, Sarah Thompson, Mark Cheng, Po-Yung Sundaram, Maria E Belongia, Edward A Griffin, Marie R BMC Infect Dis Research Article BACKGROUND: Little is known about factors associated with maintenance of hemagglutinin inhibition (HAI) antibodies after influenza vaccination in older adults. METHODS: Adults ≥50 years of age were vaccinated prior to the 2009–10 influenza season. Serum was drawn pre-vaccination (S1), 21–28 days post-vaccination (S2), and after the influenza season (S3) for HAI assays. Seroconversion was defined as ≥ 4-fold increase S1 to S2 (or if S1 < 10, by an S2 ≥ 40) and seroprotection was defined as S2 ≥ 40. Maintenance of antibody response was measured in participants with an S2 ≥ 40, and defined as an S3 ≥ 40. RESULTS: We enrolled 510 participants during Fall 2009 at Vanderbilt University Medical Center and Marshfield Clinic Research Foundation. Participants’ mean age was 64 years with 62% female and 96% white. Seroconversion and seroprotection rates were lowest for influenza A H1N1 (12% and 26%, respectively), highest for influenza A H3N2 (45% and 82%), and intermediate for influenza B (28% and 72%). Of the participants with an S2 ≥ 40, 36% (46/126), 71% (289/407), and 74% (263/354) maintained an S3 ≥ 40 for H1N1, H3N2, and B influenza vaccine strains, respectively. S1 HAI titer was strongly associated with both post-vaccination seroprotection and maintaining seroprotection at S3 for all three influenza antigens. Age, sex, body mass index, self-reported stress, and vaccination site were not consistently associated with vaccine response or maintenance of response. CONCLUSIONS: Pre-vaccination antibody titer was the only study variable consistently and positively associated with both serologic response to vaccination and maintenance of response. Antibody responses were lowest for the H1N1 vaccine strain. CLINICALTRIALS: gov Identifier: NCT02401893 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-015-0926-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-04-23 /pmc/articles/PMC4415221/ /pubmed/25903659 http://dx.doi.org/10.1186/s12879-015-0926-8 Text en © Talbot et al.; licensee Biomed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Talbot, H Keipp
Coleman, Laura A
Zhu, Yuwei
Spencer, Sarah
Thompson, Mark
Cheng, Po-Yung
Sundaram, Maria E
Belongia, Edward A
Griffin, Marie R
Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults
title Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults
title_full Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults
title_fullStr Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults
title_full_unstemmed Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults
title_short Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults
title_sort factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415221/
https://www.ncbi.nlm.nih.gov/pubmed/25903659
http://dx.doi.org/10.1186/s12879-015-0926-8
work_keys_str_mv AT talbothkeipp factorsassociatedwithmaintenanceofantibodyresponsestoinfluenzavaccineinoldercommunitydwellingadults
AT colemanlauraa factorsassociatedwithmaintenanceofantibodyresponsestoinfluenzavaccineinoldercommunitydwellingadults
AT zhuyuwei factorsassociatedwithmaintenanceofantibodyresponsestoinfluenzavaccineinoldercommunitydwellingadults
AT spencersarah factorsassociatedwithmaintenanceofantibodyresponsestoinfluenzavaccineinoldercommunitydwellingadults
AT thompsonmark factorsassociatedwithmaintenanceofantibodyresponsestoinfluenzavaccineinoldercommunitydwellingadults
AT chengpoyung factorsassociatedwithmaintenanceofantibodyresponsestoinfluenzavaccineinoldercommunitydwellingadults
AT sundarammariae factorsassociatedwithmaintenanceofantibodyresponsestoinfluenzavaccineinoldercommunitydwellingadults
AT belongiaedwarda factorsassociatedwithmaintenanceofantibodyresponsestoinfluenzavaccineinoldercommunitydwellingadults
AT griffinmarier factorsassociatedwithmaintenanceofantibodyresponsestoinfluenzavaccineinoldercommunitydwellingadults